Format

Send to

Choose Destination
Mol Med Today. 2000 Feb;6(2):66-71.

Recent advances with recombinant bacterial vaccine vectors.

Author information

1
Division of Vaccine Research, Institute of Human Virology, 725 Lombard Street, Baltimore, MD 21201, USA.

Abstract

Bacille Calmette-Guerin (BCG), Listeria monocytogenes, Salmonellae and Shigellae have shown promise as vaccine vectors in experimental animal models. Although disappointing results in humans and non-human primates stalled the development of this vaccination strategy, interest in this approach was reinvigorated recently by the development of bacterial DNA-vaccine-vectors. The purpose of this review is to highlight the strengths and weaknesses of bacterial vaccine vectors, and to discuss the future prospects of these vaccine delivery systems.

PMID:
10652479
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center